191 patents currently held
22 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
8 more records may belong here and await a decision; they are not counted.
The next term ends in Feb 2035. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Feb 2035
Next term end
135
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Feb 2040 · High confidence
Also notable
Ends Jan 2039 · High confidence
Also notable
Ends Jan 2039 · High confidence
Delivering Tumor Treating Fields (TTFields) Using Implantable Transducer Arrays
US 11,471,676
Cited by 31 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2040.
Electrode Array
US D1,010,136
Cited by 15 later US patents, top 5% of design patents granted in 2024 in our data. Protection runs to 2039.
Electrode Array
US D1,010,138
Cited by 15 later US patents, top 5% of design patents granted in 2024 in our data. Protection runs to 2039.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 18, 2027The maintenance fee for Optimizing Treatment Using TTFields by Changing the Frequency During the Course of Long Term Tumor Treatment (US 11,701,161) comes due Jan 18, 2027. Unpaid by Jul 19, 2027, it lapses early.
- 1 fee due May 14, 2027The maintenance fee for Fabricating Organic Light Emitting Diodes (OLEDs) Using Tubulin (US 11,818,943) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
- 3 fees due Jun 5 to 26, 2027 · next Jun 5
- 7 fees due Jul 2 to 30, 2027 · next Jul 2
- 4 fees due Aug 6 to 27, 2027 · next Aug 6
- 1 fee due Sep 26, 2027The maintenance fee for Methods, Systems, and Apparatuses for Image Segmentation (US 11,941,761) comes due Sep 26, 2027. Unpaid by Mar 27, 2028, it lapses early.
- 2 fees due Oct 2 to 23, 2027 · next Oct 2
Recent changes
- 22 of the patents on this record were granted since Aug 19, 2026
- 1 term has ended since Aug 19, 2026
What they patent
The 5 largest of its 135 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Conductive Pad Generating Tumor Treating Field and Methods of Production and Use Thereof | 6 in force | to Oct 2042 |
| Electrode Array (2021) | 4 in force | to Mar 2041 |
| Electrode Array (2021) | 4 in force | to Feb 2041 |
| Enhanced-Flexibility Transducer Arrays for Delivering TTFields (Tumor Treating Fields) | 4 in force | to Apr 2040 |
| Delivering Tumor Treating Fields (TTFields) Using Implantable Transducer Arrays | 4 in force | to Feb 2040 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,701,161 | Optimizing Treatment Using TTFields by Changing the Frequency During the Course of Long Term Tumor Treatment In force · High confidence | In force | High confidence | |
| US D934,892 | Display Screen or Portion Thereof with a Graphical User Interface In force · High confidence | In force | High confidence | |
| US 11,191,956 | Reducing Motility of Cancer Cells Using Tumor Treating Fields (TTFields) In force · High confidence | In force | High confidence | |
| US 11,964,146 | Arrays for Longitudinal Delivery of TTFields to a Body In force · High confidence | In force | High confidence | |
| US 11,642,514 | Optimizing Positions of Electrodes for Applying Tumor Treating Fields (TTFields) by Adding a Dipole to a 3D Model In force · High confidence | In force | High confidence | |
| US D959,673 | Electrode Array In force · High confidence | In force | High confidence | |
| US D960,375 | Electrode Array In force · High confidence | In force | High confidence | |
| US D961,091 | Electrode Array In force · High confidence | In force | High confidence | |
| US 11,879,886 | System for Viewing Cell Cultures Under a Microscope whilst Applying TTFields In force · High confidence | In force | High confidence | |
| US 11,452,863 | Arrays for Longitudinal Delivery of TTFields to a Body In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 191: 22 patents in force now held by others · 31 patents ended · 217 applications pending · 22 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.